<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=1000083763474443&amp;ev=PageView&amp;noscript=1">

SmartTRAK Life Sciences News and Analysis Blog

1 min read

SmartTRAK Publication Alert: Q317 Advanced Wound Care Quarterly Market Recap

12/19/17 9:00 AM

SmartTRAK Publication Alert Blog Post Social Media -Advanced Wound Care.png

Q317 Market Recap Advanced Wound Care 

Biologics and single-use NPWT devices’ strong growth helps boost sluggish advanced dressing performance.

By Susan Paquette, VP Wound and
Lennart Stadler, Senior Analyst Wound

For Q317, according to BioMedGPS’ SmartTRAK Financial Dashboard, WW Advanced Wound Care (AWC) revenues for Advanced Dressings, External Devices and Biologics grew in spite of a weak performance with market leaders.

The US FDA shook up the amniotic tissue market when it published “Regulatory Considerations for Human Cell, Tissues, and Cellular and Tissue-Based Products: Minimal Manipulation and Homologous Use” Final Guidance in November. The document clarifies the FDA’s position regarding amniotic tissue ...

Read entire Market Recap including news, data and analysis*...

*This article can only be viewed by SmartTRAK subscribers to this module.

Request SmartTRAK Wound Care Subscription Info

Topics: Wound Care

Susan Paquette
Written by Susan Paquette

Susan Paquette, MS, MBA | Vice President and General Manager, Wound. 25+ years' experience in new business development, R&D, international and marketing. Director, New Business Development & Commercialization, 3M Health Care; Technical Director, 3M Medical.

    Recent Articles